Paul Tudor Jones Charles River Laboratories International, Inc. Call Options Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $901,882 - $1.22 Million	-4,700 Reduced 74.6%	1,600 $321,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $492,775 - $625,175	2,500 Added 65.79%	6,300 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $474,344 - $651,404	2,600 Added 216.67%	3,800 $748,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $244,956 - $362,880	1,200 New	1,200 $256,000

721

52M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.